Cardiac amyloidosis in a patient with multiple myeloma: A case report and review of literature

Journal of Clinical Ultrasound

Volumn 37, Issue 3, 2009, Pages 179-184

  Sedaghat, David ^a   Zakir, Ramzan M ^a   Choe, Jin ^b   Klapholz, Marc ^a   Saric, Muhamed ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Veteran Administration Hospital   (United States)

Author keywords

Amyloidosis; Diastolic dysfunction; Multiple myeloma; Restrictive cardiomyopathy; Sonography

Indexed keywords

AMYLOID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; THALIDOMIDE;

ABDOMINAL PAIN; ADULT; ARTICLE; AUTOPSY; CASE REPORT; CONGESTIVE HEART FAILURE; DIASTOLIC HEART FAILURE; ELECTROCARDIOGRAPHY; HEART AMYLOIDOSIS; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; MULTIPLE MYELOMA; OXYGEN SATURATION; PHYSICAL EXAMINATION; QRS COMPLEX; TRANSTHORACIC ECHOCARDIOGRAPHY;

AMYLOIDOSIS; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, RESTRICTIVE; ECHOCARDIOGRAPHY; FATAL OUTCOME; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MULTIPLE MYELOMA; ULTRASONOGRAPHY, DOPPLER;

EID: 65349191808     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20552     Document Type: Article

References (26)

1. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450.
2. Merlini G, Bellotti V. Molecular mechanism of amyloidosis. N Engl J Med 2003;349:583.
3. Westermark P, Benson MD, Buxbaum JN, et al. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 2005;12:1.
4. Kyle RA. Amyloidosis. Circulation 1995;91:1269.
5. Klein AL, Hatle LK, Burstow DJ, et al. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990;15:99.
6. Mathew V, Olson L, Gertz MA, et al. Symptomatic conduction systems disease in cardiac amyloidosis. Am J Cardiol 1997;80:1491.
7. Al Suwaidi J, Velianou JL, Gertz MA, et al. Systemic amyloidosis presenting as angina pectoris. Ann Intern Med 1999;131:838.
8. Mueller PS, Edwards WD, Gertz MA. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med 2000;109:181.
9. Dispenzieri A, Kyle RA, Gertz MA, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003; 361:1787.
10. Nordlinger M, Magnani B, Skinner M, et al. Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol 2005;96:982.
11. Dubrey SW, Cha K, Skinner M, et al. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 1997;78:74.
12. Simons M, Isner JM. Assessment of relative sensitivities of non-invasive tests for cardiac amyloidosis in documented cardiac amyloidosis. Am J Cardiol 1992;69:425.
13. Falk RH, Plenn JF, Deering T, et al. Sensitivity and specificity of echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987;59:418.
14. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hem 2005;79:319.
15. Pellikka PA, Holmes DR Jr, Edwards WD, et al. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med 1988;148:662.
16. Koyama J, Ray-Sequin PA, Davidoff R, et al. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 2002;89:1067.
17. Oki T, Tanaka H, Yamada H, et al. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall. Am J Cardiol 2004;93:864.
18. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance imaging in cardiac amyloidosis. Circulation 2005;111:186.
19. Griffiths BE, Hughes P, Dowdle R, et al. Cardiac amyloidosis with asymmetric septal hypertrophy and deterioration after nifedipine. Thorax 1982; 37:711.
20. Pollak A, Falk RH. Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest 1993;104:618.
21. Rose EA, Gelinjins AC, Moskowitz AJ, et al. Longterm mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345: 1435.
22. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45.
23. Saba N, Sutton D, Ross H, et al. High treatmentrelated mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant 1999;24:853.
24. Dubrey SW, Burke MM, Khaghini A, et al. Long term results of heart transplantation in patients with amyloid heart disease. Heart 2001;85:202.
25. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997; 336:1202.
26. Gomenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood 2002;99:4279.